A Major Milestone For Gene Editing To Treat Cancer- New Study Finds CRISPR Can Successfully Kill Cancer Cells Without an Adverse Affect on Patients

Updated February 9th, 2020

A Major Milestone For Gene Editing To Treat Cancer- New Study Finds CRISPR Can Successfully Kill Cancer Cells Without an Adverse Affect on Patients

Overseen by the renowned immunologist Dr. Carl June, it showed the edited genes had a sustained ability to attack and kill tumors.

NOW
PLAYING
New Hope for Multiple Myeloma Patients: Study of New CAR T-cell Therapy Shows The Best Result In The History of The Disease
NOW
PLAYING
5 COVID-19 Vaccine Questions Answered by Expert Physician
NOW
PLAYING
Everyone Is Talking About Monoclonal Antibodies as Treatment For Reducing Risk of Symptomatic COVID — Is It an Option for Those With Cancer?
NOW
PLAYING
New Treatment Shows Huge Promise For Decreasing COVID Symptom-- Are Monoclonal Antibodies An Option for Cancer Patients?
NOW
PLAYING
New COVID-19 Stimulus Bill Opens Cancer Clinical Trials to Millions Who Were Previously Excluded
NOW
PLAYING
How a Clinical Trial Might Improve Your Outlook

SurvivorNetTV.
Hope. Science.
Inspiration.

Discover SNTV
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.